Copyright
©The Author(s) 2021.
World J Clin Cases. Feb 26, 2021; 9(6): 1293-1303
Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1293
Published online Feb 26, 2021. doi: 10.12998/wjcc.v9.i6.1293
Table 4 Comparison of vasopressor use between groups
| Ephedrine use (mg) | Phenylephrine use (μg) | |||
| Induction | Maintenance | Induction | Maintenance | |
| Propofol group | 7.0 ± 1.6 | 9.8 ± 3.2 | 17.5 ± 3.8 | 15.1 ± 1.6 |
| Etomidate group | 3.1 ± 2.0 | 2.6 ± 1.1 | 6.2 ± 1.3 | 7.5 ± 2.1 |
| P value | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
- Citation: Dai ZL, Cai XT, Gao WL, Lin M, Lin J, Jiang YX, Jiang X. Etomidate vs propofol in coronary heart disease patients undergoing major noncardiac surgery: A randomized clinical trial. World J Clin Cases 2021; 9(6): 1293-1303
- URL: https://www.wjgnet.com/2307-8960/full/v9/i6/1293.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i6.1293